Pfizer
PFE
PFE
3,185 hedge funds and large institutions have $196B invested in Pfizer in 2022 Q1 according to their latest regulatory filings, with 156 funds opening new positions, 1,375 increasing their positions, 1,339 reducing their positions, and 183 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less call options, than puts
Call options by funds: $ | Put options by funds: $
less funds holding
Funds holding: →
12% less capital invested
Capital invested by funds: $222B → $196B (-$25.8B)
15% less first-time investments, than exits
New positions opened: 156 | Existing positions closed: 183
34% less funds holding in top 10
Funds holding in top 10: 249 → 165 (-84)
Holders
3,185
Holding in Top 10
165
Calls
$3.18B
Puts
$3.23B
Top Buyers
| 1 | +$1.94B | |
| 2 | +$716M | |
| 3 | +$495M | |
| 4 |
Los Angeles Capital Management
Los Angeles,
California
|
+$389M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
+$389M |
Top Sellers
| 1 | -$923M | |
| 2 | -$881M | |
| 3 | -$723M | |
| 4 |
Coatue Management
New York
|
-$609M |
| 5 |
DZ Bank
Frankfurt Am Main,
Germany
|
-$527M |